AVANT Immunotherapeutics' Acquisition

AVANT Immunotherapeutics was acquired by Celldex Therapeutics on March 05, 2008.

Avant develops and markets vaccines for underserved markets. The company is developing a broad portfolio of vaccines addressing a wide range of applications including bacterial and viral diseases, car…

Articles about AVANT Immunotherapeutics' Acquisition: